MedPath

egative pressure versus standard wound therapy for diabetic foot

Phase 2
Conditions
Diabetic foot ulcers.
Personal history of diabetic foot ulcer
Z86.31
Registration Number
IRCT20231201060234N2
Lead Sponsor
CMH Peshawar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
160
Inclusion Criteria

Included all patients >18 years diagnosed clinically and BSF and 2-hour-post prandial investigations in the diabetic range according to the WHO criteria
Presenting with a diabetic foot wound of more than 4 weeks duration corresponding to Wagner grade 2 for debridement.

Exclusion Criteria

Included patients < 18 years
Pregnancy
Non-compliant to follow-up
Necrotic tissue on ulcer with eschar that could not be debrided
Malignancy, advanced cardiac and respiratory disease
Exposed nerve and vessels beneath the ulcer and patient with above ankle ulcer and those with Charcot arthropathy.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mean wound closure time. Timepoint: During or after 12 weeks of therapy. Method of measurement: Subjective assessment by 3 consultants.
Secondary Outcome Measures
NameTimeMethod
Median pain scores. Timepoint: After 12 weeks of therapy. Method of measurement: Standard Visual Analog Scale for pain and Likert scale for satisfaction.;Incidence of infection. Timepoint: During 12 weeks of therapy. Method of measurement: Subjective by 3 independent consultants.
© Copyright 2025. All Rights Reserved by MedPath